EP3273992
Mótefni gegn ICOS
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
22.3.2016EP published:
13.5.2020EP application number:
16769535.2
EP translation filed:
29.7.2020Grant published:
15.8.2020EPO information:
European Patent Register
Max expiry date:
21.3.2036Expiry date:
21.3.2024Next due date:
31.3.2024
Title:
ANTIBODIES TO ICOS
Timeline
Today
22.3.2016EP application
13.5.2020EP Publication
29.7.2020Translation submitted
15.8.2020Registration published
21.3.2024Expires
Owner
Name:
Jounce Therapeutics, Inc.Address:
780 Memorial Drive, Cambridge, MA 02139, US
Inventor
Name:
SAZINSKY, StephenAddress:
Cambridge, Massachusetts 02139, US
Name:
MICHAELSON, Jennifer S.Address:
Cambridge, Massachusetts 02139, US
Name:
SATHYANARAYANAN, SriramAddress:
Cambridge, Massachusetts 02139, US
Name:
ELPEK, Kutlu GoksuAddress:
Cambdridge, Massachusetts 02139, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562137034 PDate:
23.3.2015Country:
US
Number:
201562147484 PDate:
14.4.2015Country:
US
Number:
201562156588 PDate:
4.5.2015Country:
US
Number:
201562242489 PDate:
16.10.2015Country:
US
Number:
201562255635 PDate:
16.11.2015Country:
US
Classification
Categories:
A61K 39/395, C07K 16/28, C07K 16/46, C12P 21/08, A61K 39/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 26.3.2021
Expires: 21.3.2022
Payer: G.H. Sigurgeirsson ehf.
Number: 7
Paid: 11.3.2022
Expires: 21.3.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 8
Paid: 17.3.2023
Expires: 21.3.2024
Payer: G.H. Sigurgeirsson ehf.